Market Tracker

12/08 3:06pm ET

Alexion Pharmaceuticals Inc (NASDAQ:ALXN)

125.41
BATS BZX Real-Time Price
As of 3:06pm ET
 -0.21 / -0.17%
Today’s Change
110.56
Today|||52-Week Range
193.45
-34.25%
Year-to-Date

Today’s Trading

Previous close125.62
Today’s open126.37
Day’s range123.13 - 126.38
Volume55,731
Average volume (3 months)1,917,597
Market cap$28.2B
Dividend yield--
Data as of 3:06pm ET, 12/08/2016

Growth & Valuation

Earnings growth (last year)-79.45%
Earnings growth (this year)-6.73%
Earnings growth (next 5 years)+18.25%
Revenue growth (last year)+12.25%
P/E ratio416.2
Price/Sales16.57
Price/Book3.43

Competitors

 Today’s
change
Today’s
% change
ZTSZoetis Inc+0.16+0.31%
BAXBaxter International...-0.11-0.25%
INCYIncyte Corp-0.18-0.18%
VRTXVertex Pharmaceutica...+1.10+1.46%
Data as of 3:06pm ET, 12/08/2016

Financials

Next reporting dateFebruary 2, 2017
EPS forecast (this quarter)$1.27
Annual revenue (last year)$2.5B
Annual profit (last year)$144.4M
Net profit margin5.81%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
David L. Hallal
Executive Vice President-
Global Operations
Julie O'Neill
Corporate headquarters
New Haven, Connecticut

Forecasts